The Cooper Companies, Inc. (COO)
NASDAQ: COO · Real-Time Price · USD
82.75
+0.29 (0.35%)
At close: Dec 19, 2025, 4:00 PM EST
82.72
-0.03 (-0.04%)
After-hours: Dec 19, 2025, 7:00 PM EST
The Cooper Companies Revenue
In the fiscal year ending October 31, 2025, The Cooper Companies had annual revenue of $4.09B with 5.06% growth. The Cooper Companies had revenue of $1.07B in the quarter ending October 31, 2025, with 4.59% growth.
Revenue (ttm)
$4.09B
Revenue Growth
+5.06%
P/S Ratio
4.03
Revenue / Employee
$272,827
Employees
15,000
Market Cap
16.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2025 | 4.09B | 197.00M | 5.06% |
| Oct 31, 2024 | 3.90B | 302.20M | 8.41% |
| Oct 31, 2023 | 3.59B | 284.80M | 8.61% |
| Oct 31, 2022 | 3.31B | 385.90M | 13.20% |
| Oct 31, 2021 | 2.92B | 491.60M | 20.22% |
| Oct 31, 2020 | 2.43B | -222.50M | -8.39% |
| Oct 31, 2019 | 2.65B | 120.60M | 4.76% |
| Oct 31, 2018 | 2.53B | 393.80M | 18.41% |
| Oct 31, 2017 | 2.14B | 172.20M | 8.76% |
| Oct 31, 2016 | 1.97B | 169.70M | 9.44% |
| Oct 31, 2015 | 1.80B | 79.32M | 4.62% |
| Oct 31, 2014 | 1.72B | 130.05M | 8.19% |
| Oct 31, 2013 | 1.59B | 142.59M | 9.87% |
| Oct 31, 2012 | 1.45B | 114.30M | 8.59% |
| Oct 31, 2011 | 1.33B | 172.32M | 14.87% |
| Oct 31, 2010 | 1.16B | 78.10M | 7.23% |
| Oct 31, 2009 | 1.08B | 33.05M | 3.16% |
| Oct 31, 2008 | 1.05B | 102.14M | 10.81% |
| Oct 31, 2007 | 945.24M | 86.28M | 10.04% |
| Oct 31, 2006 | 858.96M | 52.34M | 6.49% |
| Oct 31, 2005 | 806.62M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
COO News
- 15 days ago - Cooper Companies Launches Portfolio Review To 'Unlock Value' - Benzinga
- 15 days ago - The Cooper Companies, Inc. (COO) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Cooper Companies initiates strategic review; shares jump - Reuters
- 16 days ago - CooperCompanies Announces New Chair of the Board and Strategic Review - GlobeNewsWire
- 16 days ago - CooperCompanies Announces Fourth Quarter and Full Year 2025 Results - GlobeNewsWire
- 16 days ago - Cooper Companies Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
- 4 weeks ago - Browning West Delivers Letter to The Cooper Companies Board of Directors - GlobeNewsWire
- 5 weeks ago - Jana Partners push to break up Cooper Cos. could change the stock's outlook - CNBC